DNA expression vectors for the use in the gene therapeutic treat

Drug – bio-affecting and body treating compositions – Preparations characterized by special physical form – Liposomes

Patent

Rate now

  [ 0.00 ] – not rated yet Voters 0   Comments 0

Details

514 44, A61K 3127, A61K 317088

Patent

active

061499366

ABSTRACT:
A DNA expression vector is described which is characterized in that it comprises a DNA sequence that codes a protein which possesses the biological activity of nitrogen monoxide synthase (NOS) and eukaryotic regulation elements, wherein said eukaryotic regulation elements result in the expression of said DNA sequence in eukaryotic cells, as well as the use of the expression vector for treatment or prevention of vascular disorders.

REFERENCES:
patent: 5132407 (1992-07-01), Stuehr et al.
patent: 5252479 (1993-10-01), Srivastava
patent: 5328470 (1994-07-01), Nable et al.
patent: 5428070 (1995-06-01), Cooke et al.
patent: 5468630 (1995-11-01), Billiar et al.
patent: 5658565 (1997-08-01), Billiar et al.
patent: 5766909 (1998-06-01), Xie et al.
Nature, vol. 333, Jun. 16, 1988, pp. 66-666.
Biochem, Biophys. Commun., vol. 153, No. 3, Jun. 30, 1988, pp. 1251-1256.
Gen. Pharmac, vol. 21, No. 5, 1990, pp. 575-587.
J. Clin, Invest., vol. 90, 1992, pp. 1168-1172.
J. Clin. Invest, vol. 90, 1992, pp. 1248-1253.
Biochem, Biophysc. Res. Communc., vol. 191, No. 1, Feb. 26, 1993, pp. 89-94.
Nunokawa et al., "Cloning of Inducible Nitric Ozide Synthase in Rat Vascular Smooth Muscle Cells", BioChemical and Biophysical Research Communications; vol. 191, No. 1, Feb. 26,1993, pp. 89-94.
Bucala, et al., "Advanced Glycosylation Products Quench Nitric Oxide and Mediate Defective Endothelium-Dependant Vasodilalation in Experimental Diabetes"1991 J. Clin. Invest. 87:432-438.
Charles et al.; "Cloning Characterization and Expression of a cDNA Encoding an Induable Nitric Oxide Synthase From the Human Chondrocyte" Proc. Nat'l Acad. Sci USA 1993; Dec. 1, 90(23): 11419-11423 (1993).
Charles et al.; "Cloning and Expresion of a Rat Neuronal Nitric Oxide Synthase Coding Sequence in a Bacluovirus/Insect Cell System" Biochemical and Biophysical Research Communications, vol. 196, No. 3, 1481-1489 (1993).
Chester et al., "Low Basal and Stimulated Release of Nitric Oxide in Antherosclerotic Epicardial Coronary Arteries" 1990, Lancet 336: 897-900.
Chin et al., "Inactivation of Endothelial Derived Relaxing Factor by Oxidized Lipoproteins" 1992, J. Clin. Invest. 89:10-18.
Clowes et al. "Kinetics of Cellular Proliferation After Arterial Injury" (1983) 327-333.
Draiper et al., "L-arginine-derived Nitric Oxide and the Cell-Mediated Immune Response" 1991 Res. Immunol. 142:53-602.
Forstermann et al. v Eurpoean Heart Journal (1993) 14 (Supp. I), "Isoforms of Nitric Oxide Synthase: Functions in the Cardiovascular System".
Feldman et al. "Site Specificity of Adernovirus--Medicated Gene Transfer by Hydrogelated Ballon" (Abstract) JACC Feb. 1994:1A-484A (p. 235A).
Geller et al., "Molecular Cloning And Expression of Inducible Nitric Oxide Synthase from Human Hepatocytes" 1993 PNAS 90: 3491-3495.
Geller et al.; "Should Surgeons Clone Genes" Archives of Surgery; American Medical Assocition vol. 128 pp. 1212-1220 (Nov. 1993).
Ignarro et al. "Endothelium-Derived Relaxing Factor Produced and Released from Artery and Vein in Nitric Oxide" 1987 PNAS 84: 9265-9269.
Janssens et al.; "Cloning and Expression of a cDNA Encoding Human Endothelium-Derived Relaxing Factor/Nitric Oxide Synthase" The Journal of Biological Chemistry; vol. 267, No. 21 Issue of Jul. 25 pp. 14319-14522 (1992).
Lange et al. Southwestern Internal Medicine Conference:Restenosis (Od. 1983) pp. 265-275.
Lloyd-Jones, M.D. et al.; "The Vascular Biology of Nitric Oxide and its Role In Atherogenesis" Annu. Rev. Med. 1996, 47:365-75.
Lowenstein et al.; "Cloned and expressed macrophage nitric oxide synthase contrasts with the brain enzyme" Proc. Nat'l Acad. Sci. USA; vol. 89, pp. 6711-6715, Aug. 1992.
Lyons et al., "Molecular Cloning and Functional Expression of an Inducible Nitric Oxide Synthase from a Murine Macrophage Cell Line" 1992 J. Biol. Chem 267:6370-6374.
Moncada, et al. 1991, Nitric Oxide: Physiology, Pathophysiology and Pharmacology Pharmaceuticals Reviews 43: 109-142.
Nabel et al. "Recombinant Gene Expression In Vivo within Endothelial Cells of the Arterial Wall" Science 244: 1342-1344 (1989).
Nabel et al. "Site-specific Gene Expression In Vivo by Direct Gene Transfer into the Arterial Wall" 1990 Science 249:1285-1288.
Nakane et al.; "Cloned Human Brain Nitric Oxide Synthase is Highly Expressed In Skeletal Muscle" FEBS Letters, vol. 316, No. 2, 175-180; Jan. 1993.
Nakanishi et al. Efficient Introduction of Contents of Liposomes into Cells Using Hr3 (Sendai Virus) (1985) 399-409.
Nunokawa and Tanaka, "Intererfon-Gamma Inhibits Proliferation of Rat Vascular Smooth Muscle Cells by Nitric Oxide Generation" 1992, Biochem Biophys. Res. Comm. 188: 409-415.
Nussler et al. "Stimulation of Nitric Oxide in Human Hepatocytes by Cytokines" 1992 Faseb. J., 6(5):A1834(#5200).
Nussler, et al. "Stimulation of the Nitric Oxide Synthase Pathway in Human Hepatocytes by Cytokines and Endotoxins" 1992, J. Exp. Med. 176:261-264.
Radomski et al., "The Anti-Aggregating Properties of Vascular Endothelium: Interactions Between Prostacyclin and Nitric Oxide" 1987 Br. J. Pharmac. 92: 639-646.
Sessa; "Molecular Cloning and Expression of a cDNA Encoding Endothelial Cell Nitric Oxide Synthase" The Journal of Biological Chemistry; vol. 267, No. 22, Issue of Aug. 5, pp. 15274-15276, 1992.
Steg et al. Local Delivery of Adenovirus for Percutaneous Arterial Gene Transfer (abstract) Supplement to Circulation, vol. 88, No. 4, Para 2 (Oct. 1993) p. I-660.
von der Leyen et al., "In Vivo Gene Transfer to Prevent Neointima Hyperplasia after Vascular Injury: Effect of Overexpression of Constitutive Nitric Oxide Synthase" 1994 Faseb. J. 8:A802(#4651).
von der Leyen et al., "Gene Therapy Inhibiting Vascular Lesion: In Vivo Transfer of Endothelial Cell Nitric Oxide Synthase Gene" pNAS USA 92 pp. 1137-1141 (Feb. 1995).
Werner-Felmayer et al, "Tetrahydrobiopterin-Dependent Formation of Nitrite and Nitrate Fibroblasts" 1990 J. Exp. Med. 172: 1599-1607.
Wilson et al., "Implantation of Vascular Grafts Lines with Genetically Modified Endothelial Cells" 1989, Science 244: 1344-1346.
Xie, et al. "Cloning and Characterization of Inducible Nitric Oxide Synthase from Mouse Macrophages" 1992 Science 256:225-228.
Zwiebel et al. "High-Level Recombinant Gene Expression in Rabbit Endothelial Cells Transduced by Retroviral Vectors" 1989, Science 243:220-222.

LandOfFree

Say what you really think

Search LandOfFree.com for the USA inventors and patents. Rate them and share your experience with other people.

Rating

DNA expression vectors for the use in the gene therapeutic treat does not yet have a rating. At this time, there are no reviews or comments for this patent.

If you have personal experience with DNA expression vectors for the use in the gene therapeutic treat, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and DNA expression vectors for the use in the gene therapeutic treat will most certainly appreciate the feedback.

Rate now

     

Profile ID: LFUS-PAI-O-1254395

  Search
All data on this website is collected from public sources. Our data reflects the most accurate information available at the time of publication.